News

Published on 29 Apr 2024 on FOX 23 News Albany

Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients


Article preview image

Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA,...

NYSE.MRK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Defense stars as Daniel wins third straight boys soccer Class AAA state title — at 1 a.m.

D.W. Daniel’s defense held on for so long in the Class AAA high school boys soccer state...

The Greenville News 11 May 2024

Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint

Merck has announced that its Phase III KEYNOTE-B21 (ENGOT-en11/GOG-3053) clinical trial of KEYTRU...

Clinical Trials Arena via Yahoo Finance 10 May 2024

Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years

By buying an index fund, investors can approximate the average market return. But if you pick the...

Simply Wall St. via Yahoo Finance 10 May 2024

Merck treatment for a type of uterus cancer fails trial

(Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the mai...

WSAU Wausau 9 May 2024

Dow Jones Falls After Jobless Claims Jump; Airbnb, Arm, Roblox Plunge On Earnings

Among U.S. exchange traded funds, the Nasdaq 100 tracker Invesco QQQ Trust ETF fell 0.3%, as the...

Investor's Business Daily 9 May 2024

2 No-Brainer Dividend Stocks to Buy in May

Dividends may be boring but are essential to building a well-balanced portfolio. After all, divid...

Motley Fool via Yahoo Finance 9 May 2024

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a goo...

Zacks via Yahoo Finance 9 May 2024

Merck's endometrial cancer therapy fails trial

The drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,...

Reuters via Yahoo News 9 May 2024

Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.

Every pharmaceutical company is constantly searching for its next blockbuster — the billion-dolla...

Quartz 8 May 2024

Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market

Among the best stocks to watch, Dow Jones drug giant Merck, Nvidia, Chipotle Mexican Grill and NX...

Investor's Business Daily 6 May 2024